IT small-cap 8K Miles jumps on fund buying
Published on Thursday, September 18, 2014 12:05 PM
Market Eye - Cloud solutions provider 8K Miles Software Services gains 10 percent to an all time-high of 390.50 rupees. ...
Sundaram BNP Paribas bought 175,000 shares at 331.95 rupees per share via a block deal on Wednesday, according to BSE data.
DSP BlackRock Mutual Fund bought 221,
India's rice output, exports to climb on revival of monsoon
Published on Thursday, September 18, 2014 12:02 PM
By Rajendra Jadhav and Mayank Bhardwaj
MUMBAI/NEW DELHI - India's summer-sown rice output is likely to cross the previous year's level due to a pick up in monsoon rains, raising prospects for higher overseas sales in 2015 by the world's biggest exporter of the grain, trade officials said.
India ships in 50 pct more Iranian oil in Jan-Aug - trade
Published on Thursday, September 18, 2014 11:45 AM
By Nidhi Verma ...
NEW DELHI - Indian imports of Iranian oil rose by nearly half to 271,000 barrels per day (bpd) in January-August from a year ago, when refineries cut purchases due to worries about insurance coverage for processing crude from Tehran, data from trade sources shows.
Sensex gains, seen better insulated from Fed worries
Published on Thursday, September 18, 2014 11:25 AM
The BSE Sensex and Nifty rose on Thursday, heading for a second straight session of gains after hitting a nearly 2-1/2 week low on Tuesday. ...
The benchmark BSE Sensex and the broader Nifty gained 1.2 percent as of 11:15 a.m.
Shares of blue-chips rose.
Larsen & Toubro gained 2.5 percen
Colgate-Palmolive gains; UBS upgrades to 'buy'
Published on Thursday, September 18, 2014 10:30 AM
Market Eye - Colgate-Palmolive (India) Ltd gains 1.6 percent. UBS upgrades the stock to "buy" from "neutral," raises target price to 1,950 rupees from 1,800 rupees.
UBS says it is "positive about the brand" as urban consumers buy into oral care products.
Sun Pharma gains; becomes first to license drug from innovator
Published on Thursday, September 18, 2014 10:28 AM
Market Eye - Sun Pharmaceutical Industries gains 2 percent. Merck & Co Inc said it had licensed its experimental psoriasis drug to Sun. ...
First instance of an Indian company taking global rights for a novel drug, traders say.
Deal strengthens Sun's presence in the U.S.
Alibaba in talks with Snapdeal to enter India - Economic Times
Published on Thursday, September 18, 2014 9:44 AM
MUMBAI - Chinese e-commerce giant Alibaba is in talks with online retailer Snapdeal to enter India, the Economic Times reported on Thursday, citing two people aware of the development. ...
Alibaba, whose shares are set to debut on the U.S. market on Friday in what could be the world's largest ever initial pub
U.S. to press India on trade row during Modi's Washington visit
Published on Thursday, September 18, 2014 9:23 AM
By David Brunnstrom ...
WASHINGTON - The United States said on Wednesday it will press India's new prime minister to end his blockage of a global trade pact when he visits Washington this month, something that could dampen the mood of a trip aimed at revitalizing strategic ties.
Merck licenses experimental psoriasis drug to Sun Pharma
Published on Thursday, September 18, 2014 9:28 AM
Merck & Co Inc said it had licensed its experimental psoriasis drug to Indian generic maker Sun Pharmaceutical Industries Ltd for $80 million. ...
Under the agreement, Sun Pharma will acquire the worldwide rights to the drug, tildrakizumab, for all possible indications.
The drug is currently in late-stage tri